View More Recent Stories
-
Trump picks RFK Jr for HHS — Here are potential policy implications
-
UnitedHealth Group (UNH), Humana (HUM) gain as Bernstein says Trump win positive for MCOs
-
Elevance (ELV) PT Lowered to $548 at JPMorgan
-
Elevance (ELV) PT Lowered to $484 at TD Cowen
-
Elevance (ELV) PT Lowered to $529 at Jefferies
-
Elevance (ELV) PT Lowered to $515 at Leerink Partners
-
Elevance (ELV) PT Lowered to $520 at Truist Securities
-
Elevance (ELV) PT Lowered to $478 at RBC Capital
-
Increasing unusual put option volume: ELV LAC CNC MGNI FITB WEN EOSE EWW ASHR OKLO
-
Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on Revenue
-
Elevance Health (ELV) call put ratio 1 call to 1.9 puts into quarter results
-
Baird Reiterates Outperform Rating on Elevance (ELV)
-
Elevance Health (ELV) October 485 straddle priced into quarter results
-
Elevance (ELV) PT Lowered to $589 at TD Cowen
-
Elevance (ELV) PT Lowered to $625 at Baird
-
BofA Securities Downgrades Elevance (ELV) to Neutral
-
Elevance (ELV) PT Raised to $585 at RBC Capital
-
Elevance (ELV) PT Lowered to $600 at Jefferies
-
Morgan Stanley Reiterates Overweight Rating on Elevance (ELV)
-
Truist Securities Reiterates Buy Rating on Elevance (ELV)
-
Elevance Health Inc. (ELV) Tops Q2 EPS by 11c
-
TD Cowen Reiterates Buy Rating on Elevance (ELV)
-
Morgan Stanley Starts Elevance (ELV) at Overweight
-
Medicare Advantage Plans Quality Ratings To Be Recalculated - WSJ
-
Elevance Health (ELV) 30-day option implied volatility flat

